- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Joann Sciandra on the Need to Combine Technology With Successful Case Management
You need both technology and successful case management to succeed in value-based care, explained Joann Sciandra, RN, BSN, CCM, associate vice president of healthcare management, Geisinger Health System.
You need both technology and successful case management to succeed in value-based care, explained Joann Sciandra, RN, BSN, CCM, associate vice president of healthcare management, Geisinger Health System.
Transcript
How does a combination of technology and successful case management help achieve value-based care?
You need both. You truly need both. Technology is good, but it’s a tool in our tool box. With case managers, we have a big tool box that has lots of tools, and we don’t just rely on one tool to drive an outcome if we’re going to call a physician if some is having an exacerbation of a chronic disease. So, what the technology does for us is it opens our eyes. It says, “Hey, the patient might be getting in trouble, let’s pick up the phone, let’s give them a call, let’s do a home visit.” We need to move to the next level to see really what’s wrong with that patient. Having them really work together is what drives the success, not working separately.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS
June 24th 2025In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.
Read More
